Intermittent Fasting Patterns: Which Protocol Actually Works for You?

Understanding why intermittent fasting produces metabolic benefits requires understanding what happens physiologically as you move from the fed to the fasted state.

In the fed state (0–4 hours after eating), insulin is elevated, promoting glucose uptake and glycogen synthesis, and inhibiting fat breakdown. Fat oxidation is minimal.

In the early fasted state (4–12 hours), blood glucose normalises, insulin declines, glucagon rises. The liver begins releasing glucose from glycogen stores. Fat mobilisation begins.

In the fasted state (12–24 hours), glycogen stores are significantly depleted. Fat oxidation increases substantially. Ketone production begins, particularly in the liver. Growth hormone secretion increases — partly a metabolic adaptation to preserve muscle and mobilise fat.

Autophagy — the cellular process of recycling damaged proteins and organelles — increases significantly after 16–24 hours of fasting. This process is believed to be relevant to cancer prevention, longevity, and neuroprotection, though most autophagy research in humans is still early-stage.

Insulin sensitivity improves with regular fasting cycles, as the pancreas experiences periods of rest and cells are not chronically exposed to elevated insulin.

The 16:8 protocol — 16 hours of fasting, 8-hour eating window — is the most widely practised and most extensively studied form of intermittent fasting in humans. Eating is typically compressed into a window like 12pm–8pm or 10am–6pm, meaning breakfast is skipped and dinner is the final meal.

The appeal is its compatibility with daily life. Most of the fasting window overlaps with sleep. The only real behaviour change is delaying the first meal and avoiding late-night eating.

A 2020 randomised controlled trial in the New England Journal of Medicine (TIME study) compared 16:8 to unrestricted eating in adults with obesity and found no significant difference in weight loss over 12 weeks when caloric intake was matched. This suggests 16:8 does not produce metabolic magic beyond caloric restriction. However, multiple other studies have found that 16:8 naturally reduces caloric intake by 200–500 calories per day without conscious restriction — because there are simply fewer hours in which to eat.

For metabolic benefits, 16:8 with an early eating window (eating between 7am and 3pm) shows stronger effects on insulin sensitivity, blood pressure, and appetite hormones than late eating windows, according to research from the Salk Institute. Circadian alignment — matching eating to daylight hours — amplifies the metabolic benefits.

The 5:2 protocol involves eating normally for five days per week and significantly restricting calories (typically 500–600 kcal) on two non-consecutive days. Popularised by Dr Michael Mosley and the book The Fast Diet, it gained widespread attention in the early 2010s.

The appeal is flexibility — fasting days can be moved around the week to accommodate social events, and the two days of restriction feel manageable because they end within 24 hours. For people who struggle with daily fasting windows, the episodic nature of 5:2 is less disruptive to routine.

Research on 5:2 shows comparable weight loss to daily caloric restriction over 12–24 weeks. A large meta-analysis published in JBI Evidence Synthesis found 5:2 effective for weight loss in overweight and obese adults, with effects on insulin and fasting glucose comparable to continuous energy restriction.

One concern is that fasting days can trigger overeating on non-fasting days if hunger is not managed carefully — particularly in people who undereat protein on fast days. Ensuring that the 500–600 calories on fasting days centres on protein (eggs, lean meat, legumes) maximises satiety and muscle protein preservation.

Alternate day fasting (ADF) involves alternating between fasting days (zero or very low calorie intake) and eating days. It is more intensive than 16:8 or 5:2 and shows the strongest effects on weight loss and metabolic markers in research — but also has the highest dropout rates.

A 2017 JAMA Internal Medicine trial comparing ADF to daily caloric restriction found comparable weight loss at 6 months, with ADF participants showing greater reductions in LDL cholesterol and greater muscle preservation relative to fat loss.

Extended fasts of 24–72 hours are practised by some individuals for purposes of autophagy enhancement, immune system regeneration, or insulin sensitisation. A 72-hour fast in oncology patients before chemotherapy is being studied for potentially protective effects. However, extended fasting beyond 24 hours is not necessary for most health and weight goals, and carries risks including muscle breakdown, electrolyte disturbance, and refeeding syndrome if not managed correctly.

For most people, ADF or extended fasting is not the right starting point. 16:8 or 5:2 provides most of the metabolic benefits with far greater sustainability.

IF tends to work particularly well for:

**People with insulin resistance or prediabetes.** Reducing the hours of carbohydrate/insulin exposure is directly mechanistically relevant to improving insulin sensitivity.

**People who do not enjoy eating breakfast.** Forcing breakfast on people who are not hungry in the morning often adds rather than reduces calories. 16:8 gives these individuals permission to follow their natural appetite.

**People who prefer simplicity over tracking.** Rather than monitoring every gram of food, the rule is simply 'stop eating after 8pm and do not eat until noon'. That simplicity drives adherence.

**People who tend to eat out of habit or boredom in the evenings.** Closing the eating window at 8pm eliminates late-night snacking, which accounts for a significant proportion of excess caloric intake for many people.

IF works less well for athletes with high training loads, pregnant and breastfeeding women, people with a history of eating disorders, those who experience hypoglycaemia, and shift workers with highly irregular sleep-wake cycles.

The most common mistake is treating the eating window as a permission to eat anything. Intermittent fasting does not neutralise a diet of ultra-processed foods and excessive calories. Studies show that when IF participants are given ad libitum access to junk food during their eating windows, they often eat enough to compensate for the restricted eating hours.

A second mistake is eating too little protein. During IF, protein intake needs to be prioritised within the eating window. Insufficient protein accelerates muscle loss, reduces satiety, and impairs metabolic adaptation. Aim for 1.6–2.2g per kg of body weight distributed across the eating window.

A third mistake is abandoning IF too quickly during the adaptation period. The first 1–2 weeks of IF often involve hunger, headaches, and disrupted energy, particularly if transitioning from frequent meals or high-carbohydrate eating. These symptoms resolve for most people within 2 weeks as metabolic flexibility improves.

A fourth mistake is not accounting for social life. Rigid adherence that makes every social meal stressful or impossible undermines the sustainability that makes IF valuable. Build in flexibility — occasional deviation from the window does not erase accumulated benefits.